These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17642618)

  • 1. In-vitro lymphocyte toxicity to a phenytoin metabolite in phenytoin induced cutaneous adverse drug eruptions.
    Dwivedi R; Gogtay N; Kharkar V; Amladi S; Kshirsagar N
    Indian J Dermatol Venereol Leprol; 2004; 70(4):217-20. PubMed ID: 17642618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticonvulsant toxicity in vitro: possible role of arene oxides.
    Spielberg SP; Gordon GB; Blake DA; Mellits ED; Bross DS
    J Pharmacol Exp Ther; 1981 May; 217(2):386-9. PubMed ID: 7229980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predisposition to phenytoin hepatotoxicity assessed in vitro.
    Spielberg SP; Gordon GB; Blake DA; Goldstein DA; Herlong HF
    N Engl J Med; 1981 Sep; 305(13):722-7. PubMed ID: 6790991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitrofurantoin cytotoxicity. In vitro assessment of risk based on glutathione metabolism.
    Spielberg SP; Gordon GB
    J Clin Invest; 1981 Jan; 67(1):37-41. PubMed ID: 7451657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro assessment of pharmacogenetic susceptibility to toxic drug metabolites in humans.
    Spielberg SP
    Fed Proc; 1984 May; 43(8):2308-13. PubMed ID: 6714438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rapid in vitro assay for evaluation of metabolism-dependent cytotoxicity of antiepileptic drugs on isolated human lymphocytes.
    Tabatabaei AR; Thies RL; Farrell K; Abbott FS
    Fundam Appl Toxicol; 1997 Jun; 37(2):181-9. PubMed ID: 9242591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum sickness-like reactions to cefaclor: role of hepatic metabolism and individual susceptibility.
    Kearns GL; Wheeler JG; Childress SH; Letzig LG
    J Pediatr; 1994 Nov; 125(5 Pt 1):805-11. PubMed ID: 7965438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an in vitro assay for the investigation of metabolism-induced drug hepatotoxicity.
    Otto M; Hansen SH; Dalgaard L; Dubois J; Badolo L
    Cell Biol Toxicol; 2008 Jan; 24(1):87-99. PubMed ID: 17549590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Halothane hepatitis. Detection of a constitutional susceptibility factor.
    Farrell G; Prendergast D; Murray M
    N Engl J Med; 1985 Nov; 313(21):1310-4. PubMed ID: 4058523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticonvulsant hypersensitivity syndrome: lymphocyte toxicity assay for the confirmation of diagnosis and risk assessment.
    Bavdekar SB; Muranjan MN; Gogtay NJ; Kantharia V; Kshirsagar NA
    Ann Pharmacother; 2004 Oct; 38(10):1648-50. PubMed ID: 15304627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticonvulsant-induced aplastic anemia: increased susceptibility to toxic drug metabolites in vitro.
    Gerson WT; Fine DG; Spielberg SP; Sensenbrenner LL
    Blood; 1983 May; 61(5):889-93. PubMed ID: 6831050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of antiepileptic drugs on immune system].
    Basta-Kaim A; Budziszewska B; LasoĊ„ W
    Przegl Lek; 2008; 65(11):799-802. PubMed ID: 19205364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic drug monitoring of antiepileptic drugs.
    Shakya G; Malla S; Shakya KN; Shrestha R
    JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting possible zonisamide hypersensitivity syndrome.
    Neuman MG; Shear NH; Malkiewicz IM; Kessas M; Lee AW; Cohen L
    Exp Dermatol; 2008 Dec; 17(12):1045-51. PubMed ID: 18637135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic E-codes for commonly used, narrow therapeutic index medications poorly predict adverse drug events.
    Leonard CE; Haynes K; Localio AR; Hennessy S; Tjia J; Cohen A; Kimmel SE; Feldman HI; Metlay JP
    J Clin Epidemiol; 2008 Jun; 61(6):561-71. PubMed ID: 18471660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic predisposition to phenytoin-induced birth defects.
    Strickler SM; Dansky LV; Miller MA; Seni MH; Andermann E; Spielberg SP
    Lancet; 1985 Oct; 2(8458):746-9. PubMed ID: 2864485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption.
    Kano Y; Hirahara K; Mitsuyama Y; Takahashi R; Shiohara T
    Allergy; 2007 Dec; 62(12):1439-44. PubMed ID: 17983378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous drug eruptions: a 5-year experience.
    Gerson D; Sriganeshan V; Alexis JB
    J Am Acad Dermatol; 2008 Dec; 59(6):995-9. PubMed ID: 19022101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple drug allergy in patients with cutaneous adverse drug reactions diagnosed by in vitro drug-induced interferon-gamma release.
    Halevy S; Grossman N
    Isr Med Assoc J; 2008 Dec; 10(12):865-8. PubMed ID: 19160944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.